Joya Chandra

7.5k total citations · 1 hit paper
159 papers, 5.9k citations indexed

About

Joya Chandra is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Joya Chandra has authored 159 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 33 papers in Hematology and 25 papers in Genetics. Recurrent topics in Joya Chandra's work include Histone Deacetylase Inhibitors Research (27 papers), Childhood Cancer Survivors' Quality of Life (22 papers) and Cell death mechanisms and regulation (18 papers). Joya Chandra is often cited by papers focused on Histone Deacetylase Inhibitors Research (27 papers), Childhood Cancer Survivors' Quality of Life (22 papers) and Cell death mechanisms and regulation (18 papers). Joya Chandra collaborates with scholars based in United States, India and Sweden. Joya Chandra's co-authors include Sten Orrenius, Afshin Samali, David J. McConkey, Claudia P. Miller, Kanchugarakoppal S. Rangappa, Mary E. Irwin, Michael A. Palladino, C. T. Sadashiva, Richard J. Bold and Michael J. Keating and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Joya Chandra

152 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Triggering and modulation of apoptosis by oxidative stress

2000 1.2k citations Joya Chandra, Sten Orrenius et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joya Chandra United States	40	3.3k	964	727	548	500	159	5.9k
Mario Dicato Luxembourg	57	5.1k 1.6×	1.6k 1.6×	814 1.1×	1.1k 2.0×	1.1k 2.2×	219	10.8k
Kenneth K. Chan United States	47	5.0k 1.5×	1.3k 1.4×	542 0.7×	930 1.7×	446 0.9×	172	8.1k
Sanjay Kumar United States	25	3.5k 1.1×	1.2k 1.2×	1.0k 1.4×	178 0.3×	737 1.5×	87	6.3k
Gilberto Schwartsmann Brazil	43	2.4k 0.7×	1.8k 1.9×	516 0.7×	218 0.4×	306 0.6×	244	6.2k
Julie A. Reisz United States	42	2.4k 0.7×	366 0.4×	605 0.8×	729 1.3×	238 0.5×	168	5.9k
Yuqin Wang China	47	3.8k 1.2×	1.3k 1.3×	704 1.0×	177 0.3×	378 0.8×	271	7.4k
Vijay K. Singh United States	46	2.0k 0.6×	797 0.8×	1.1k 1.5×	238 0.4×	252 0.5×	234	6.6k
James T. Dalton United States	55	3.4k 1.0×	1.4k 1.4×	241 0.3×	249 0.5×	1.6k 3.2×	203	9.6k
Christophe P. Stove Belgium	47	2.2k 0.7×	512 0.5×	1.7k 2.4×	497 0.9×	235 0.5×	267	7.2k
Shazib Pervaiz Singapore	58	5.9k 1.8×	1.3k 1.4×	1.0k 1.4×	222 0.4×	477 1.0×	176	9.9k

Countries citing papers authored by Joya Chandra

Since Specialization

Citations

This map shows the geographic impact of Joya Chandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joya Chandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joya Chandra more than expected).

Fields of papers citing papers by Joya Chandra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joya Chandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joya Chandra. The network helps show where Joya Chandra may publish in the future.

Co-authorship network of co-authors of Joya Chandra

This figure shows the co-authorship network connecting the top 25 collaborators of Joya Chandra. A scholar is included among the top collaborators of Joya Chandra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joya Chandra. Joya Chandra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chandra, Joya, et al.. (2024). Virtual Screening and Pharmacophore Modeling for discovery of Biologically Active Natural Products as Inhibitors of Odorant-binding Proteins. Asian Journal of Research in Chemistry. 17–24.

Jeyabal, Prince, Anchit Bhagat, Fei Wang, et al.. (2023). Circulating microRNAs and Cytokines as Prognostic Biomarkers for Doxorubicin-Induced Cardiac Injury and for Evaluating the Effectiveness of an Exercise Intervention. Clinical Cancer Research. 29(21). 4430–4440. 6 indexed citations

Amini, Behrang, J. Andrew Livingston, Michelle A.T. Hildebrandt, et al.. (2023). Poor Sit-to-Stand Performance in Adolescent and Young Adult Patients with Sarcoma. Journal of Adolescent and Young Adult Oncology. 12(6). 821–827. 1 indexed citations

Ma, Huaxian, Mansour Alfayez, Fei Wang, et al.. (2023). Cigarette smoke exposure accelerates AML progression in FLT3-ITD models. Blood Advances. 7(21). 6624–6629. 2 indexed citations

Sharma, Monika, Carlos E. Espinoza, Varunkumar Krishnamoorthy, et al.. (2023). Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor Recurrence. Molecular Cancer Therapeutics. 23(1). 24–34. 4 indexed citations

Irwin, Mary E., Shelley M. Herbrich, Tiewei Cheng, et al.. (2022). Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy. Antioxidants. 11(4). 717–717. 25 indexed citations

Roth, Michael, J. Andrew Livingston, Michelle A.T. Hildebrandt, et al.. (2021). Short-Term Changes in Skeletal Muscle Mass After Anthracycline Administration in Adolescent and Young Adult Sarcoma Patients. Journal of Adolescent and Young Adult Oncology. 11(3). 320–322. 6 indexed citations

Sun, Yusha, et al.. (2020). Pediatric high-grade glioma: aberrant epigenetics and kinase signaling define emerging therapeutic opportunities. Journal of Neuro-Oncology. 150(1). 17–26. 8 indexed citations

Wu, Jimin, et al.. (2020). High Rates of Obesity at Presentation Persist into Survivorship across Childhood Cancer Types. Childhood Obesity. 16(4). 250–257. 9 indexed citations

10.

Kannan, Sankaranarayanan, Shelley M. Herbrich, Leonard S. Golfman, et al.. (2019). Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia. Molecular Cancer Therapeutics. 18(9). 1615–1627. 9 indexed citations

11.

Swartz, Maria C., Karen Basen‐Engquist, Christine Markham, et al.. (2016). Psychometric Analysis of the Three-Factor Eating Questionnaire-R18V2 in Adolescent and Young Adult-Aged Central Nervous System Tumor Survivors. Journal of Adolescent and Young Adult Oncology. 5(3). 278–285. 5 indexed citations

12.

Corrales‐Medina, Fernando F., et al.. (2015). Efficacy of panobinostat and marizomib in acute myeloid leukemia and bortezomib-resistant models. Leukemia Research. 39(3). 371–379. 17 indexed citations

13.

Beltran, Alicia, Joann L. Ater, Janice Baranowski, et al.. (2013). Adapting a Videogame to the Needs of Pediatric Cancer Patients and Survivors. Games for Health Journal. 2(4). 213–221. 10 indexed citations

14.

Miller, Claudia P., et al.. (2011). Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors. BioMed Research International. 2011(1). 514261–514261. 70 indexed citations

15.

Kopetz, Scott, Donald P. Lesslie, Serk In Park, et al.. (2009). Synergistic Activity of the Src Family Kinase Inhibitor Dasatinib and Oxaliplatin in Colon Carcinoma Cells Is Mediated by Oxidative Stress. Cancer Research. 69(9). 3842–3849. 127 indexed citations

16.

Ahmed, Faiyaz, Joya Chandra, Asna Urooj, & Kanchugarakoppal S. Rangappa. (2009). In vitro antioxidant and anticholinesterase activity of Acorus calamus and Nardostachys jatamansi rhizomes.. Journal of Pharmacy Research. 2(5). 830–833. 14 indexed citations

17.

Palladino, Michael A., et al.. (2008). Overlapping functional activities of proteasome inhibitor, NPI-0052, and HDAC inhibitors contribute to synergistic cytotoxicity in leukemia cells. Cancer Research. 68. 3255–3255. 1 indexed citations

18.

Kagan, Valerian E., Yulia Y. Tyurina, Vladimir A. Tyurin, et al.. (2002). A Role for Oxidative Stress in Apoptosis: Oxidation and Externalization of Phosphatidylserine Is Required for Macrophage Clearance of Cells Undergoing Fas-Mediated Apoptosis. The Journal of Immunology. 169(1). 487–499. 209 indexed citations

19.

Nutt, Leta K., Joya Chandra, Abujiang Pataer, et al.. (2002). Bax-mediated Ca2+ Mobilization Promotes Cytochrome c Release during Apoptosis. Journal of Biological Chemistry. 277(23). 20301–20308. 167 indexed citations

20.

Multani, Asha S., Mustafa Özen, Joya Chandra, et al.. (2000). Caspase-Dependent Apoptosis Induced by Telomere Cleavage and TRF2 Loss. Neoplasia. 2(4). 339–345. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact